Chemed Corp (NYSE:CHE)
$ 558.27 3.55 (0.64%) Market Cap: 8.36 Bil Enterprise Value: 8.22 Bil PE Ratio: 28.21 PB Ratio: 6.77 GF Score: 95/100

Chemed Corp at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 11:00PM GMT
Release Date Price: $573.22 (+1.24%)
Andrew Lang

Good afternoon, everyone. Thank you for joining us this week at the JPMorgan Healthcare Conference. My name is Andrew Lang, and I'm an associate here on the JPMorgan health care team. It is my pleasure to introduce Kevin McNamara, President and CEO of Chemed; Nick Westfall, CEO of VITAS; and Mike Witzeman, CFO of Chemed.

With that, Kevin, I'll turn it over to you.

Kevin J. McNamara
Chemed Corporation - CEO, President & Director

Thank you. Whenever I speak in with the group that is bigger than maybe [4 and 111], I always like to start with a little bit of history of Chemed because the question is bagged, what was the grand strategy between -- behind putting a hospice company together with a plumbing company? And so I'll just spend a couple of minutes talking about it. Chemed was a subsidiary of W.R. Grace & Company during the '70s.

At that point, it had a couple of specialty chemical companies and some health care companies. And it spun off the health care companies as Omnicare, a company now I guess part of CVS. And during the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot